Atlas Trials

The Expression of Immune Checkpoint CD28 rs1980422-related Single-nucleotide Polymorphisms in the Primary Immune Thrombocytopenia

Clinical trial NCT05468866 · UNKNOWN

Trial details

NCT number
NCT05468866
Sponsor
Sohag University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2022-09-01
Primary completion
2023-03-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.